Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study.

Hidde SwartjesDaan W P van LankveldFelice N van ErningHenk M W VerheulJohannes H W de WiltTijmen KoëterPauline A J Vissers

Published in: Annals of surgical oncology (2022)

The cumulative incidence of LRCC was low, and adjuvant chemotherapy was associated with a decreased risk for LRCC among targeted patients. Curative-intent treatment was given to nearly 1 in 4 LRCC patients, and the OS for this group was high.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
risk factors
patient reported outcomes
cancer therapy
smoking cessation
combination therapy